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Introduction
Primary headache is a very common complaint in childhood
and adolescence and, contrary to what one might think, is
highly disabling. Given the elevated prevalence of headache,
the degree of disability and the compromise in the quality of
life of young patients, it is no surprise that it represents an
important public health problem with considerable costs for
the National Health Care System and for their families.
Until now, some studies have been published on the eco-
nomic burden of headache, in particular migraine, in terms
of both direct and indirect costs in the adult population,
assessed as lost work and reduced work productivity during
headache attacks [1–4]. Other studies have evaluated the
indirect costs, which are not readily quantifiable, such as
time lost due to non-work-related activities [5] and degree of
disability [6, 7]. Only a few of these studies in the adult pop-
ulation also considered the juvenile age group [8–10].
In contrast, studies are lacking that focus attention on
childhood. Such lack of data is due in part to the scarce
interest concerning juvenile headache, at least until now,
and in part to the difficulty of quantifying the indirect
costs in this population, in that children are not directly
involved in the productivity process.
Materials and methods
Twenty-five patients (11 M and 14 F), mean age 13 years (range
7–18), were referred to our Child and Adolescent Neuropsychia-
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Abstract Headache, and in particu-
lar migraine, is a common distur-
bance in childhood and adoles-
cence. The disabling nature of
headache, evident in the adult,
together with its effects on family
life and reduction in performance
of scholastic activity, make it a dis-
ease with an elevated social eco-
nomic impact. We present prelimi-
nary results of a prospective study
conducted over 6 months on a pop-
ulation of headache sufferers in
childhood and adolescence who
referred to our Juvenile
Neuropsychiatry Centre of the
Hospital of Perugia. Our objective
was to quantify the direct and indi-
rect costs associated with juvenile
headache.
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try Centre suffering from headache. The diagnosis of headache
was made according to the ICHD-II criteria (2004): 10 patients
had migraine without aura (MO); 4 migraine with aura (MA); 3
episodic tension-type headache (ETH); 4 chronic tension-type
headache (CTH); 2 chronic migraine (CM); and 2 headache sec-
ondary to sinusitis.
The study analysed the direct costs of headache, represented
by the expenses for paediatric and specialist visits, diagnostic
testing, and symptomatic and/or prophylactic pharmacological
therapy, and the indirect costs, considering the economic equiv-
alent of lost work hours by the parents to care for their child.
Moreover, in the indirect costs we also considered lost school
hours by the child due to headache.
The costs of the visits and the diagnostic testing were calcu-
lated using the National Price List, the costs of prescription med-
icine were based on their price to the public and the economic
equivalent of lost work hours was based on the National
Collective Work Contract.
Data were collected by means of a “cost diary”, which was
distributed at the first visit along with the headache diary, in
which the parents reported, in relation to the headache attacks,
eventual paediatric and specialist visits or emergency depart-
ment visits, therapy undertaken, lost school hours and lost work
hours by the parents to care for their children.
For each child, at the end of the study period, a form was
filled out with the data obtained from the “cost diary” and from
the clinical chart, in which the visits and the diagnostic testing
performed for the patient were reported.
Results
The data indicate for these subjects an overall cost of €
18,614.30; the total direct cost was € 17,290, repre-
sented by visits and diagnostic testing for 92.94%, and
by symptomatic and/or prophylactic pharmacological
therapy for 7.06%. In Figure 1 the average costs per
patient are reported. The average expense for each
patient was € 691.60. An analysis of the average direct
costs per patient in relation to the different types of
headaches yields a greater expense per MA patient of €
802.80, of which 92.84% was due to diagnostic testing
and 7.16% to drug costs, followed by CM (€ 760.50, of
which 76.13% was due to diagnostic testing and 23.87%
to drug costs) and headache secondary to sinusitis (€
692, of which 87.28% was due to diagnostic testing and
12.72% to drug costs).
The total indirect cost was € 1323.30 with an average
indirect cost per patient of € 52.97. Moreover, a greater
number of lost work hours was recorded by the parents of
the group of children affected by CM, as was a greater
number of hours lost by the children in scholastic activity.
Discussion
The preliminary data of our on-going study show how,
even in childhood and adolescence, the economic costs of
headache for quantifiable expenses impose a significant
burden on the National Health Care System and on the
families of the young headache patients.
Obviously, a larger population-based epidemiologic
study on a national level is desirable to evaluate the eco-
nomic impact of juvenile headache on the National Health
Care System and to lay the groundwork for a rational use
of resources to allocate for financing health expenditures.
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Fig. 1 Average direct costs (€) per patient
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